| 1 | support medchem and structurebased | | | | | | | 2 | 0.65% |
| 2 | crystal systems for challenging | | | | | | | 2 | 0.65% |
| 3 | of crystals at multiple | | | | | | | 2 | 0.65% |
| 4 | solution xray data collection | | | | | | | 2 | 0.65% |
| 5 | by the client or | | | | | | | 2 | 0.65% |
| 6 | provided by the client | | | | | | | 2 | 0.65% |
| 7 | libraries provided by the | | | | | | | 2 | 0.65% |
| 8 | establishing new crystal systems | | | | | | | 2 | 0.65% |
| 9 | new crystal systems for | | | | | | | 2 | 0.65% |
| 10 | diverse chemical space – | | | | | | | 2 | 0.65% |
| 11 | at multiple synchrotrons and | | | | | | | 2 | 0.65% |
| 12 | highly diverse chemical space | | | | | | | 2 | 0.65% |
| 13 | fragment screening covering a | | | | | | | 2 | 0.65% |
| 14 | compound structural analysis parallel | | | | | | | 2 | 0.65% |
| 15 | structural analysis parallel screening | | | | | | | 2 | 0.65% |
| 16 | analysis parallel screening of | | | | | | | 2 | 0.65% |
| 17 | medchem and structurebased drug | | | | | | | 2 | 0.65% |
| 18 | and structurebased drug design | | | | | | | 2 | 0.65% |
| 19 | crystals at multiple synchrotrons | | | | | | | 2 | 0.65% |
| 20 | data collection and structure | | | | | | | 2 | 0.65% |
| 21 | biomolecules including ligand and | | | | | | | 2 | 0.65% |
| 22 | crystaldirect™ crims about contact | | | | | | | 2 | 0.65% |
| 23 | including ligand and binding | | | | | | | 2 | 0.65% |
| 24 | ligand and binding site | | | | | | | 2 | 0.65% |
| 25 | diffusion of ligands increasing | | | | | | | 1 | 0.32% |
| 26 | scientists in realtime through | | | | | | | 1 | 0.32% |
| 27 | suitable for all crystal | | | | | | | 1 | 0.32% |
| 28 | and results and makes | | | | | | | 1 | 0.32% |
| 29 | crystal harvesting suitable for | | | | | | | 1 | 0.32% |
| 30 | automated crystal harvesting suitable | | | | | | | 1 | 0.32% |
| 31 | results and makes them | | | | | | | 1 | 0.32% |
| 32 | available to scientists in | | | | | | | 1 | 0.32% |
| 33 | to scientists in realtime | | | | | | | 1 | 0.32% |
| 34 | on laserinduced photoablation highthroughput | | | | | | | 1 | 0.32% |
| 35 | of crystals based on | | | | | | | 1 | 0.32% |
| 36 | based on laserinduced photoablation | | | | | | | 1 | 0.32% |
| 37 | crystals based on laserinduced | | | | | | | 1 | 0.32% |
| 38 | experiments and results and | | | | | | | 1 | 0.32% |
| 39 | in realtime through intuitive | | | | | | | 1 | 0.32% |
| 40 | realtime through intuitive interfaces | | | | | | | 1 | 0.32% |